Results 21 to 30 of about 90,057,531 (289)

Can NGOs Regulate Medicines Markets? Social Enterprise in Wholesaling, and Access to Essential Medicines. [PDF]

, 2011
Citizens of high income countries rely on highly regulated medicines markets. However low income countries' impoverished populations generally struggle for access to essential medicines through out-of-pocket purchase on poorly regulated markets; results ...
Mujinja, P.G.M, Chaudhuri, Sudip, Mujinja Phares GM, Mackintosh Maureen, Maureen Mackintosh, Mackintosh, M., Phares GM Mujinja, Sudip Chaudhuri, Mujinja, Phares Gm, Mujinja, Phares G.M., Mackintosh, Maureen, Chaudhuri Sudip, Chaudhuri, S.   +12 more
core   +1 more source

Implementation of Medicines Pricing Policies in Ghana: The Interplay of Policy Content, Actors’ Participation, and Context [PDF]

International Journal of Health Policy and Management, 2023
Background  Implementing medicines pricing policy effectively is important for ensuring equitable access to essential medicines and ultimately achieving universal health coverage. However, published analyses of policy implementations are scarce from low-
Augustina Koduah, Leonard Baatiema, Irene A. Kretchy, Irene Akua Agyepong, Anthony Danso-Appiah, Anna Cronin de Chavez, Timothy Ensor, Tolib Mirzoev   +7 more
doaj   +1 more source

Essential medicines and access to insulin [PDF]

The Lancet Diabetes & Endocrinology, 2017
We fully support the views expressed in The Lancet Diabetes & Endocrinology's Editorial about ensuring affordable access to insulin and the proposal to add analogue insulin to the WHO Essential Medicines list. The International Insulin Foundation in its 2011 position statement called for “the universal access for persons with type 1 diabetes to life ...
Gill, Geoff, Yudkin, John S, Tesfaye, Solomon, de Courten, Maximilian, Gale, Edwin, Motala, Ayesha, Ramaiya, Kaushik, Unwin, Nigel, Wild, Sarah   +8 more
openaire   +3 more sources

A win-win solution?: A critical analysis of tiered pricing to improve access to medicines in developing countries [PDF]

, 2011
Background: Tiered pricing - the concept of selling drugs and vaccines in developing countries at prices systematically lower than in industrialized countries - has received widespread support from industry, policymakers, civil society, and academics as ...
Childs, Michelle, Childs Michelle, Moon Suerie, Elodie Jambert, Moon, Suerie, von Schoen-Angerer, Tido, Jambert Elodie, Jambert, Elodie, Michelle Childs, von Schoen-Angerer Tido, Suerie Moon, Tido von Schoen-Angerer   +11 more
core   +1 more source

Driving a decade of change: HIV/AIDS, patents and access to medicines for all [PDF]

, 2011
Since 2000, access to antiretroviral drugs to treat HIV infection has dramatically increased to reach more than five million people in developing countries.
Moon, Suerie, Calmy, Alexandra, Jonathan Berger, Alexandra Calmy, Hoen, Ellen 't, Berger, Jonathan, Suerie Moon, Ellen 't Hoen   +7 more
core   +1 more source

Embracing context: Lessons from designing a dialogue-based intervention to address vaccine hesitancy

Frontiers in Public Health, 2023
Dialogue with people who are vaccine hesitant has been recommended as a method to increase vaccination uptake. The process of cultivating dialogue is shaped by the context in which it occurs, yet the development of interventions addressing vaccine ...
ToTran Nguyen, ToTran Nguyen, Lise Boey, Carla Van Riet, Stef Dielen, Hélène Dodion, Tamara Giles-Vernick, Nico Vandaele, Heidi J. Larson, Koen Peeters Grietens, Koen Peeters Grietens, Charlotte Gryseels, Leonardo W. Heyerdahl   +12 more
doaj   +1 more source

TRIPS, the Doha declaration and paragraph 6 decision: what are the remaining steps for protecting access to medicines? [PDF]

, 2007
BACKGROUND: The World Trade Organisation's Declaration on the TRIPS Agreement and Public Health (known as the Doha Declaration) of 2001, and subsequent Decision on the Interpretation of Paragraph 6 reached in 2003, affirmed the flexibilities available ...
Kerry Vanessa, Vanessa Kerry, Lee, Kelley, Kerry, Vanessa Bradford, Lee Kelley, Kelley Lee   +5 more
core   +1 more source

Towards a Patent Pool for HIV Medicines: The Background [PDF]

, 2010
Recent WHO guidelines for antiretroviral therapy recommend switching to less toxic, but more expensive medicines for first-line and second-line ART, raising questions about the financial sustainability of many AIDS treatment programmes. At the same time,
Childs, Michelle
core   +1 more source

Pharmaceutical policies and regulations of oral antiviral drugs for treatment of hepatitis C in Egypt—case study

Journal of Pharmaceutical Policy and Practice, 2021
Background There are limited studies on the role of efficient regulatory mechanisms in facilitating greater access to Hepatitis C virus (HCV) treatment. Evidence to support the importance of effective pharmaceutical policies and regulations in improving ...
Mahmoud H. Teaima, Adi Al-Nuseirat, Dalia Abouhussein, Osama A. Badary, Mohamed A. El-Nabarawi   +4 more
doaj   +1 more source

New diagnostics for tuberculosis: fulfilling patient needs first

Journal of the International AIDS Society, 2010
Background An effective tuberculosis (TB) control programme requires early diagnosis and immediate initiation of treatment. Any delays in diagnosing TB not only impair a patient's prognosis, but also increase the risks of transmitting the disease within ...
Jean‐François Lemaire, Martina Casenghi   +1 more
doaj   +1 more source